Journal of Medicinal Chemistry p. 4669 - 4678 (2002)
Update date:2022-08-02
Topics:
Haque, Tasir S.
Tadesse, Seifu
Marcinkeviciene, Jovita
Rogers, M. John
Sizemore, Christine
Kopcho, Lisa M.
Amsler, Karen
Ecret, Lisa D.
Zhan, Dong Liang
Hobbs, Frank
Slee, Andrew
Trainor, George L.
Stern, Andrew M.
Copeland, Robert A.
Combs, Andrew P.
The identification of several potent pyrazole-based inhibitors of bacterial dihydroorotate dehydrogenase (DHODase) via a directed parallel synthetic approach is described below. The initial pyrazole-containing lead compounds were optimized for potency against Helicobacter pylori DHODase. Using three successive focused libraries, inhibitors were rapidly identified with the following characteristics: Ki < 10 nM against H. pylori DHODase, sub-μg/mL H. pylori minimum inhibitory concentration activity, low molecular weight, and > 10 000-fold selectivity over human DHODase.
View MoreALPHA PHARMACEUTICAL CO,LTD JIANGSU
Contact:+86-527-84829968,+86-527-84829998
Address:suqian city
Jinzhou Jiutai Pharmaceutical Co.,Ltd
Contact:+86-0416-5179890
Address:No.41, Taianli, Taihe District, Jinzhou, Liaoning
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Tianjin Dongchang Fine Chemical Industry Co., Ltd.
Contact:+86-22-29894595
Address:Economic Developing Zone, Ji County, Tianjin, China
Shanghai Sharing technologies Co., Ltd.
Contact:86-021-66787223
Address:No11, Lane 225, Jinxiang Road,Pudong district
Doi:10.1007/BF01145565
(1987)Doi:10.1246/bcsj.74.2325
(2001)Doi:10.1021/om970578q
(1997)Doi:10.1016/S0040-4039(97)01586-4
(1997)Doi:10.1021/jm400383w
(2013)Doi:10.1016/S0968-0896(97)00107-7
(1997)